Clinical Trial Update: A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors [Phase 1]

View source ↗

Summary

BL-M24D1 is being studied in a Phase 1 trial for locally advanced or metastatic head and neck squamous cell carcinoma and other solid tumors. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• BL-M24D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma, Solid Tumor | Phase 1 | Status: RECRUITING